Compania Cervecerias Unidas S.A. (CCU)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 24, 2025 | $0.03 | 2024-11-22 | 2024-11-22 |
| July 24, 2025 | $0.02 | 2024-04-23 | 2024-04-24 |
| May 13, 2025 | $0.21 | 2025-04-24 | 2025-04-24 |
| December 13, 2024 | $0.24 | 2024-11-22 | 2024-11-22 |
| July 22, 2024 | $0.01 | 2023-04-20 | 2023-04-21 |
Dividends Summary
- Compania Cervecerias Unidas S.A. has issued 81 dividend payments over the past 22 years
- The most recent dividend was paid 58 days ago, on July 24, 2025
- The highest dividend payed out to investors during this period was $3 per share
- The average dividend paid during this period was $0.32 per share.
Company News
Ambev has a stable brand-name business model and high profit margins. Read what makes ABEV stock an attractive foreign investment.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Tuesday. The Dow traded down 0.92% to 33,562.53 while the NASDAQ fell 1.75% to 11,826.47. The S&P 500, also fell, dropping, 1.40% to 4,079.31. Check This Out: Bitcoin, Ethereum Record Losses; PancakeSwap Becomes Top Loser Leading and Lagging Sectors Consumer staples shares rose by 0.1% on Tuesday. Meanwhile, top gainers in the sector included Compañía Cervecerías Unidas S.A. (NYSE: CCU), up 4%, and Utz Brands, Inc. (NYSE: UTZ), up 3%. In trading on Tuesday, energy shares dipped by 2.1%. Top Headline McDonald's Corp (NYSE: MCD) reported better-than-expected results for its first quarter. McDonald's reported first-quarter FY23 sales growth of 4% year-on-year to $5.89 billion, beating the consensus of $5.59 billion. Adjusted EPS of $2.63 beat the analyst consensus of $2.33. Equities Trading UP Virios Therapeutics, Inc. (NASDAQ: VIRI) shares shot up 32% to $2.0992 after the company announced initial FDA feedback on its proposed IMC-1 Phase 3 program for the treatment of fibromyalgia. The company said the proposed program is considered acceptable based on initial FDA feedback pending review of the final chronic toxicology program results. Shares of Spectrum Pharmaceuticals, Inc. ...